Header Logo

Connection

AURIS HUEN to Minimal Clinically Important Difference

Back to Details
This is a "connection" page, showing publications AURIS HUEN has written about Minimal Clinically Important Difference.
AURIS HUEN
Connection Strength
0.047
Minimal Clinically Important Difference
  1. Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2021 02; 21(2):97-105.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.